Tickers

1. Composite Trajectory Verdict

For a bank holding company, the income statement and balance sheet carry the most weight because profitability (net interest margin, efficiency, returns) and capital adequacy/asset quality are the primary drivers of financial performance, while cash flow is heavily influenced by deposit fluctuations and merger-related non-cash items.

Composite Trajectory: Mixed

The GAAP income statement shows expanding net interest margin (3.61% vs 2.95%) and higher net interest income, but net income grew only 5% while diluted EPS fell 38% due to a 67% increase in shares outstanding from the merger; return on average assets declined to 0.69% from 1.00% and return on average equity fell to 7.04% from 11.80%. The balance sheet strengthened with equity-to-assets rising to 10.55% from 9.56% and total risk-based capital at 12.5%, yet reported nonperforming loans jumped to 0.98% of loans from 0.24% (73% merger-related) and the allowance ratio increased to 1.18% from 1.07%. Operating cash flow dropped 32% to $31.8M, while investing cash flow turned positive only due to $173M of merger-related cash receipts.

2. Red Flags

• Provision for credit losses surged to $14.8M in 2025 from $0.6M in 2024, driven by a $12.0M charge for non-PCD loans acquired in the merger (10-K 2025-12-31, MD&A Provision and Allowance For Credit Losses).
• Merger-related noninterest expenses of $17.4M in 2025 versus $1.0M in 2024, with no further material merger expenses anticipated (10-K 2025-12-31, MD&A Noninterest Expense).
• Nonperforming loans increased to $29.6M (0.98% of loans) at 12/31/2025 from $4.2M (0.24%) at 12/31/2024, with $21.8M (73%) acquired in the merger (10-K 2025-12-31, MD&A Loans).
• Diluted EPS fell 38% to $2.01 in 2025 from $3.25 in 2024 despite a 5% rise in net income, due to 6,070,836 shares issued for the merger (10-K 2025-12-31, Selected Financial Data; Shareholders' Equity).
• Operating cash flow declined to $31.8M in 2025 from $47.1M in 2024, while the positive investing cash flow of $106.7M was primarily $173.1M of cash received in the merger (10-K 2025-12-31, Consolidated Statements of Cash Flows; MD&A Liquidity and Interest Rate Risk).
• Unrealized losses on investment securities totaled $90.0M at 12/31/2025 ($52.8M AFS, $37.2M HTM), with HTM losses not reflected in accumulated other comprehensive income (10-K 2025-12-31, MD&A Securities).
• Cash dividend payout ratio jumped to 60.2% of net income in 2025 from 33.7% in 2024, attributed to merger-related expenses causing a net income loss in Q1 2025 (10-K 2025-12-31, MD&A Dividends).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: Net interest income rose 84% to $137.1M in 2025 from $74.4M in 2024, and GAAP net interest margin expanded 66 basis points to 3.61%, driven by loan growth (including $1.4B from the merger) and $13.1M of purchase-loan accretion income (10-K 2025-12-31, Selected Financial Data; MD&A Net Interest Income). Noninterest income increased 37% to $24.7M, but noninterest expense nearly doubled to $112.7M, including $17.4M of merger costs (10-K 2025-12-31, MD&A Noninterest Expense). The provision for credit losses jumped to $14.8M from $0.6M, largely due to the $12.0M non-PCD loan charge (10-K 2025-12-31, MD&A Provision and Allowance For Credit Losses). Net income grew 5% to $28.2M, yet diluted EPS fell 38% to $2.01 because the share count rose 67% (10-K 2025-12-31, Selected Financial Data). Return on average assets declined to 0.69% from 1.00%, and return on average equity fell to 7.04% from 11.80% (10-K 2025-12-31, Selected Financial Data).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Overall Assessment: Net cash provided by operating activities decreased 32% to $31.8M in 2025 from $47.1M in 2024, reflecting higher amortization/accretion on purchased loans and a decline in other liabilities (10-K 2025-12-31, Consolidated Statements of Cash Flows; MD&A Liquidity and Interest Rate Risk). Investing cash flow swung to a $106.7M inflow from a $96.3M outflow, but this was almost entirely due to $173.1M of cash received in the merger, partially offset by $95.6M of securities purchases and $78.9M of securities sales (10-K 2025-12-31, Consolidated Statements of Cash Flows). Financing cash flow was a $147.3M outflow versus a $90.6M inflow in 2024, driven by a $48.0M net deposit outflow, $80.2M net repayment of short-term borrowings, $16.9M of dividends, and $2.7M of share repurchases (10-K 2025-12-31, Consolidated Statements of Cash Flows). The net change in cash and cash equivalents was -$8.8M in 2025 compared to +$41.3M in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Total assets grew 62% to $4.41B at 12/31/2025 from $2.72B at 12/31/2024, primarily from the merger (10-K 2025-12-31, Consolidated Balance Sheets). Gross loans increased 95% to $3.02B, with $1.4B from the merger and $86.1M organic core loan growth (5.7%) (10-K 2025-12-31, MD&A Loans). Deposits rose 63% to $3.60B, with $1.3B from the merger excluding brokered deposits (10-K 2025-12-31, MD&A Deposits and Other Funding Sources). Shareholders' equity increased 79% to $465.4M, boosted by $193.0M of common stock issued for the merger, plus $11.2M retained earnings growth and a $2.1M improvement in accumulated other comprehensive loss (10-K 2025-12-31, MD&A Shareholders' Equity). Equity-to-assets improved to 10.55% from 9.56%, and the bank remained well-capitalized with a 12.5% total risk-based capital ratio (10-K 2025-12-31, Selected Financial Data; MD&A Shareholders' Equity). However, the allowance for credit losses to loans ratio rose to 1.18% from 1.07%, and nonperforming loans to loans jumped to 0.98% from 0.24%, with 73% of nonperforming loans acquired in the merger (10-K 2025-12-31, MD&A Provision and Allowance For Credit Losses; Loans). Unrealized losses on securities totaled $90.0M, including $37.2M in held-to-maturity securities not reflected in equity (10-K 2025-12-31, MD&A Securities).

6. Data Gaps

• Quarterly income statement, cash flow, and balance sheet trends for 2025 (Q1-Q4) and 2026 (Q1-Q2) are not available in the provided filings; the 10-Qs for those periods were listed but their contents were not included in the supplied text.
• Organic (non-merger) quarterly trends for net interest margin, provision expense, and noninterest expense cannot be isolated from the provided annual data.
• The 2026 estimated accretion income of $8.0M and remaining $53.1M of purchase-loan accretion are forward-looking estimates, not reported results (10-K 2025-12-31, MD&A Net Interest Income).
• Detailed loan portfolio credit quality migration data (e.g., risk rating changes) for the post-merger period is not provided in the annual filing.
• The impact of the January 2026 sale of $201.0M of pay-fixed interest rate swaps on future earnings and equity is disclosed only as a subsequent event (10-K 2025-12-31, MD&A Securities; Note 25).